Japan vs Malaysia: Proportion of isolates with decreased susceptibility or resistance
Japan
3.7
in 2020
Malaysia
6.8
in 2020
Japan rank
5th
Malaysia rank
3rd
Proportion of isolates with decreased susceptibility or resistance over time
- Japan
- Malaysia
How they compare
Malaysia currently reports 6.8 against 3.7 in Japan, a difference of 3.1.
That makes Malaysia's figure about 1.8 times Japan's.
The two have swapped places 3 times across 5 shared years of data; in 2009 it was Japan ahead.
Japan ranks 5th and Malaysia ranks 3rd of 52 countries.
Across the 3 decades both report, Japan averaged higher in 2 and Malaysia in 1.
Head to head by decade
| Decade | Japan | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.35 | 0 | 20.35 | Japan |
| 2010s | 13.43 | 6.05 | 7.38 | Japan |
| 2020s | 3.7 | 6.8 | 3.1 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Japan or Malaysia?
- Malaysia, at 6.8 against 3.7 in Japan as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Japan and Malaysia?
- 3.1, with Malaysia ahead.
- How many years of comparable data are there for Japan and Malaysia?
- 5 years are reported by both, from 2009 to 2020.
- How do Japan and Malaysia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Japan ranks 5th and Malaysia ranks 3rd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.